St. Michaels Hospital
Toronto M5B1W8
8 studies enrolling now · 23 studies all time
What they study most
ARDS, Acute Gastrointestinal Bleeding, Atrial Functional Mitral Regurgitation, Biliary Tract Cancer, Bronchial Diseases, Cardiac Valve Disease, Cervical Spinal Cord Injury, Cholangiocarcinoma, Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps, Cold Agglutinin Disease, Coronary Artery Disease, Cystic Fibrosis
Studies at this site
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
- Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding — Recruiting now
- Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19) — Recruiting now
- CRS Questionnaire Validation Project — Recruiting now
- Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR) — Recruiting now
- CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting — Recruiting now
- Cross-sectional Characterization of Idiopathic Bronchiectasis — Completed
- Intravascular Neuro OCT Imaging System for Aneurysm Treatment Evaluation — Running, not enrolling
- Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment — Enrolling by invitation
- Edwards EVOQUE Eos MISCEND Study — Running, not enrolling
- Incomplete Cervical SCI Without Instability — Running, not enrolling
- Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER) — Completed
- A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD) — Completed
- MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect — Running, not enrolling
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting — Enrolling by invitation
- Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors — Stopped early
- A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
- A Study Evaluating the Long-term Safety of VX-445 Combination Therapy — Completed
- Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis — Completed
- A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy — Stopped early
- A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed
- A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed
- Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications — Completed